TAZ is a novel oncogene in non-small cell lung cancer. (Q38337901)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

TAZ is a novel oncogene in non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Z Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Y Hao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

N Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

L Raptis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

X Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

24 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

2181-2186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Pathogenesis of lung cancer signalling pathways: roadmap for therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Mouse models of lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Tumor suppressor LATS1 is a negative regulator of oncogene YAP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Hippo signaling in organ size control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

A translational view of the molecular pathogenesis of lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Filling out the Hippo pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Molecular genetics of lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

LATS2 tumour specific mutations and down-regulation of the gene in non-small cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

New molecularly targeted therapies for lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

LATS tumor suppressor: A new governor of cellular homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

New insights of epithelial-mesenchymal transition in cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Molecular footprints of human lung cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

The Hippo-YAP pathway: new connections between regulation of organ size and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.606

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21258416%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 January 2020

1036331650

0 references

1 reference